Weed (BUDZ) EBITDA (2010 - 2026)

Weed's (BUDZ) quarterly EBITDA came in at -$163955.0 in Q1 2026, up 62.29% year-on-year from -$101028.2 in Q1 2025, and up 77.44% quarter-over-quarter from -$726874.0 in Q4 2025.

Weed (BUDZ) EBITDA (2010 - 2026) Analysis & Trends

Weed's EBITDA history runs 13 years deep, the most recent figure standing at -$163955.0 for Q1 2026.

  • On a quarterly basis, EBITDA rose 62.29% year-over-year to -$163955.0 in Q1 2026; TTM through Mar 2026 was -$1.1 million, a 31.5% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 million, down 150.51% from the prior year.
  • EBITDA rose to -$163955.0 in Q1 2026 per BUDZ's latest filing, from -$726874.0 in the prior quarter.
  • Across five years, EBITDA topped out at -$32746.0 in Q4 2023 and bottomed at -$726874.0 in Q4 2025.
  • The 5-year median for EBITDA is -$159878.0 (2023), against an average of -$241391.9.
  • Across the five-year window, EBITDA soared 88.66% in 2023 and slumped 470.27% in 2025, its largest moves.
  • Year by year, EBITDA stood at -$288861.0 in 2022, then surged by 88.66% to -$32746.0 in 2023, then sank by 289.24% to -$127462.0 in 2024, then slumped by 470.27% to -$726874.0 in 2025, then surged by 77.44% to -$163955.0 in 2026.
  • Per Business Quant, the three latest BUDZ EBITDA figures stand at -$163955.0 (Q1 2026), -$726874.0 (Q4 2025), and -$66897.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 652.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 833.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -2.65 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 325.80 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -79.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 193.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 291.00 Mn
10 Weed 3.72 Mn 3.72 Mn - -163,955.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -163,955.00
Dec 31, 2025 -726,874.00
Sep 30, 2025 -66,897.00
Jun 30, 2025 -94,045.00
Mar 31, 2025 -434,737.00
Dec 31, 2024 -127,462.00
Sep 30, 2024 -92,649.00
Jun 30, 2024 -144,955.00
Mar 31, 2024 -159,204.00
Dec 31, 2023 -32,746.00
Sep 30, 2023 -238,824.00
Jun 30, 2023 -156,163.00
Mar 31, 2023 -159,878.00
Dec 31, 2022 -288,861.00
Sep 30, 2022 -277,960.00
Jun 30, 2022 -407,313.00
Mar 31, 2022 -531,140.00
Dec 31, 2021 -461,338.00
Sep 30, 2021 -169,910.00
Jun 30, 2021 -1.21 Mn